Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jul 9, 2024 and Jul 9, 2024. 2 other organizations filed here. The comment window closed 749d ago.

What Association for Accessible Medicines filed (1)

Abstract

The USPTO proposes to amend the rules of practice to add a new requirement for an acceptable terminal disclaimer that is filed to obviate (that is, overcome) nonstatutory double patenting. The proposed rule change would require terminal disclaimers filed to obviate nonstatutory double patenting to include an agreement by the disclaimant that the patent in which the terminal disclaimer is filed, or any patent granted on an application in which a terminal disclaimer is filed, will be enforceable only if the patent is not tied and has never been tied directly or indirectly to a patent by one or more terminal disclaimers filed to obviate nonstatutory double patenting in which: any claim has been finally held unpatentable or invalid as anticipated or obvious by a Federal court in a civil action or by the USPTO, and all appeal rights have been exhausted; or a statutory disclaimer of a claim is filed after any challenge based on anticipation or obviousness to that claim has been made. This action is being taken to prevent multiple patents directed to obvious variants of an invention from potentially deterring competition and to promote innovation and competition by allowing a competitor to avoid enforcement of patents tied by one or more terminal disclaimers to another patent having a claim finally held unpatentable or invalid over prior art.

• Association for Accessible MedicinesTHIS ORG

  1 filing · confidence 97%
• Advanced Medical Technology Associationtrade assoc.

  1 filing · confidence 97%
• Alliance for Automotive Innovationtrade assoc.

  1 filing · confidence 97%